Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$159.20 /

+3.24 (+2.08%)

, AMGN

Amgen

$204.55 /

+5.67 (+2.85%)

11:57
12/01/21
12/01
11:57
12/01/21
11:57

FDA approves J&J, Amgen treatments for multiple myeloma

The Food and Drug Administration announced the approval of Johnson & Johnson's (JNJ) daratumumab plus hyaluronidase-fihj and Amgen's (AMGN) carfilzomib plus dexamethasone for adult patients with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy. Reference Link

JNJ

Johnson & Johnson

$159.20 /

+3.24 (+2.08%)

AMGN

Amgen

$204.55 /

+5.67 (+2.85%)

  • 03

    Dec

  • 07

    Dec

  • 08

    Dec

  • 19

    Dec

  • 25

    Jan

OTHER BREAKING NEWS FROM THE FLY

Syndicate
SuperCom files to sell 5.65M ordinary shares for holders  17:39
05/27/22
05/27
17:39
05/27/22
17:39
SPCB

SuperCom

/

+

 
ShowHide Related Items >><<
SPCB SuperCom
/

+

SPCB SuperCom
/

+

Syndicate
Olympic Steel files $200M mixed securities shelf  17:38
05/27/22
05/27
17:38
05/27/22
17:38
ZEUS

Olympic Steel

$36.33 /

-0.29 (-0.79%)

 
ShowHide Related Items >><<
ZEUS Olympic Steel
$36.33 /

-0.29 (-0.79%)

ZEUS Olympic Steel
$36.33 /

-0.29 (-0.79%)

Syndicate
Rain Therapeutics files automatic mixed securities shelf  17:37
05/27/22
05/27
17:37
05/27/22
17:37
RAIN

Rain Therapeutics

$2.50 /

+0.19 (+8.23%)

 
ShowHide Related Items >><<
RAIN Rain Therapeutics
$2.50 /

+0.19 (+8.23%)

RAIN Rain Therapeutics
$2.50 /

+0.19 (+8.23%)

16:15 Today Piper Sandler
Rain Therapeutics price target lowered to $12 from $26 at Piper Sandler
03/31/22 Oppenheimer
Rain Therapeutics initiated with an Outperform at Oppenheimer
01/03/22 Guggenheim
Rain Therapeutics price target lowered to $20 from $26 at Guggenheim
11/10/21 Piper Sandler
Rain Therapeutics price target raised to $26 from $25 at Piper Sandler
RAIN Rain Therapeutics
$2.50 /

+0.19 (+8.23%)

Hot Stocks
Akerna to implement plan to reduce workforce » 17:33
05/27/22
05/27
17:33
05/27/22
17:33
KERN

Akerna

/

+

Akerna announced that the…

Akerna announced that the company is implementing a plan to reduce its workforce and operating costs in order to focus its resources, accelerate its path to profitability, and create stakeholder value. The company anticipates reporting $690,000 in total costs in its second quarter to implement the reduction in force, including the following cost elements: $630,000 in severance and associated payroll taxes; $40,000 in legal costs; and $20,000 in employee insurance benefits. Of the total cost, $440,000 in salaries, payroll taxes and benefits costs would have been reported in its second quarter if the reduction in force had not been implemented. "Our sales performance in 2022 has thus far met our expectations. We believe we are showing signs of progress with revenue now at a run rate of $27m at last filing," commented Jessica Billingsley, Akerna's Chief Executive Officer. "While we believe we can continue to grow revenue and continue to reduce expenses over time, we have made the decision to focus our initiatives on our enterprise business and new market expansion of our SMB business, at least until the market conditions and the regulatory environment are in more favorable territory. We can see a path to positive cash flows and profitability, and the board and the management team are committed to getting there on an accelerated timetable. While we continue to deal with liquidity concerns, our headcount reduction and additional cost savings measures represent a material annual cost savings. As part of this restructure, executive leadership team has also collectively agreed to a 25% reduction in salary to help support the company's cost savings initiatives. As we noted on our last earnings call, bookings have been strong and our CARR is $21.1 million, and we are looking to continue to grow our top-line through a combination of enterprise wins as well as the opportunity we see in new market expansion from the SMB side of the business," added Ms. Billingsley.

ShowHide Related Items >><<
KERN Akerna
/

+

KERN Akerna
/

+

05/11/22 Alliance Global Partners
Akerna downgraded to Neutral from Buy at Alliance Global Partners
05/11/22 H.C. Wainwright
Akerna price target lowered to $1.50 from $2.50 at H.C. Wainwright
03/22/22 Lake Street
Akerna downgraded to Hold from Buy at Lake Street
03/22/22 Alliance Global Partners
Akerna price target lowered to $2.50 from $5 at Alliance Global Partners
KERN Akerna
/

+

Hot Stocks
Northrop Grumman awarded $254.42M Navy contract modification » 17:21
05/27/22
05/27
17:21
05/27/22
17:21
NOC

Northrop Grumman

$470.76 /

+5.37 (+1.15%)

Northrop Grumman was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NOC Northrop Grumman
$470.76 /

+5.37 (+1.15%)

NOC Northrop Grumman
$470.76 /

+5.37 (+1.15%)

05/12/22 Argus
Northrop Grumman price target raised to $495 from $420 at Argus
04/29/22 UBS
Northrop Grumman price target raised to $450 from $410 at UBS
03/29/22 Jefferies
Northrop among biggest beneficiaries of DoD budget request, says Jefferies
03/07/22 Wells Fargo
Northrop Grumman price target raised to $472 from $390 at Wells Fargo
NOC Northrop Grumman
$470.76 /

+5.37 (+1.15%)

NOC Northrop Grumman
$470.76 /

+5.37 (+1.15%)

NOC Northrop Grumman
$470.76 /

+5.37 (+1.15%)

NOC Northrop Grumman
$470.76 /

+5.37 (+1.15%)

Hot Stocks
Raytheon Technologies awarded $624.6M Army contract modification » 17:17
05/27/22
05/27
17:17
05/27/22
17:17
RTX

Raytheon Technologies

$96.67 /

+1.735 (+1.83%)

Raytheon was awarded a…

Raytheon was awarded a $624.6M modification to contract for the procurement of Stinger missiles and associated equipment. Work locations and funding will be determined with each order, with an estimated completion date of June 30, 2026. U.S. Army Contracting Command is the contracting activity.

ShowHide Related Items >><<
RTX Raytheon Technologies
$96.67 /

+1.735 (+1.83%)

RTX Raytheon Technologies
$96.67 /

+1.735 (+1.83%)

04/27/22 Argus
Raytheon Technologies price target raised to $112 from $100 at Argus
04/27/22 Cowen
Raytheon Technologies price target raised to $120 from $115 at Cowen
04/08/22 RBC Capital
Raytheon Technologies initiated with an Outperform at RBC Capital
03/29/22 Jefferies
Northrop among biggest beneficiaries of DoD budget request, says Jefferies
RTX Raytheon Technologies
$96.67 /

+1.735 (+1.83%)

RTX Raytheon Technologies
$96.67 /

+1.735 (+1.83%)

RTX Raytheon Technologies
$96.67 /

+1.735 (+1.83%)

RTX Raytheon Technologies
$96.67 /

+1.735 (+1.83%)

Syndicate
Entera Bio files to sell 3.76M ordinary shares for holders  17:13
05/27/22
05/27
17:13
05/27/22
17:13
ENTX

Entera Bio

$2.28 /

+0.12 (+5.56%)

 
ShowHide Related Items >><<
ENTX Entera Bio
$2.28 /

+0.12 (+5.56%)

ENTX Entera Bio
$2.28 /

+0.12 (+5.56%)

01/24/22 B. Riley
Entera Bio price target lowered to $6 from $11 at B. Riley
01/06/22 B. Riley
B. Riley 'puzzled' by Entera Bio selloff after FDA agreement
10/07/21 B. Riley
Entera Bio price target lowered to $11 from $14 at B. Riley
06/24/21 B. Riley
Entera Bio price target raised to $14 from $9 at B. Riley
ENTX Entera Bio
$2.28 /

+0.12 (+5.56%)

Syndicate
Entera Bio files $100M mixed securities shelf  17:10
05/27/22
05/27
17:10
05/27/22
17:10
ENTX

Entera Bio

$2.28 /

+0.12 (+5.56%)

 
ShowHide Related Items >><<
ENTX Entera Bio
$2.28 /

+0.12 (+5.56%)

ENTX Entera Bio
$2.28 /

+0.12 (+5.56%)

01/24/22 B. Riley
Entera Bio price target lowered to $6 from $11 at B. Riley
01/06/22 B. Riley
B. Riley 'puzzled' by Entera Bio selloff after FDA agreement
10/07/21 B. Riley
Entera Bio price target lowered to $11 from $14 at B. Riley
06/24/21 B. Riley
Entera Bio price target raised to $14 from $9 at B. Riley
ENTX Entera Bio
$2.28 /

+0.12 (+5.56%)

Hot Stocks
Range Resources CFO sells $1.8M in common stock » 17:08
05/27/22
05/27
17:08
05/27/22
17:08
RRC

Range Resources

$36.15 /

+1.4551 (+4.19%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RRC Range Resources
$36.15 /

+1.4551 (+4.19%)

RRC Range Resources
$36.15 /

+1.4551 (+4.19%)

04/25/22 Susquehanna
Range Resources price target raised to $34 from $24 at Susquehanna
04/21/22 Truist
Range Resources price target raised to $37 from $33 at Truist
04/21/22 Piper Sandler
Range Resources upgraded to Overweight from Neutral at Piper Sandler
04/11/22 Benchmark
Range Resources price target raised to $43 from $33 at Benchmark
RRC Range Resources
$36.15 /

+1.4551 (+4.19%)

RRC Range Resources
$36.15 /

+1.4551 (+4.19%)

RRC Range Resources
$36.15 /

+1.4551 (+4.19%)

Syndicate
Immix Biopharma files to sell 1.68M shares of common stock » 17:03
05/27/22
05/27
17:03
05/27/22
17:03
IMMX

Immix Biopharma

$2.67 /

-0.33 (-11.00%)

ThinkEquity acted as sole…

ThinkEquity acted as sole book running manager for the offering.

ShowHide Related Items >><<
IMMX Immix Biopharma
$2.67 /

-0.33 (-11.00%)

  • 16
    Dec
IMMX Immix Biopharma
$2.67 /

-0.33 (-11.00%)

On The Fly
What You Missed On Wall Street On Friday » 16:39
05/27/22
05/27
16:39
05/27/22
16:39
GPS

Gap

$11.60 /

+0.45 (+4.04%)

, WDAY

Workday

$158.56 /

-9.5 (-5.65%)

, ULTA

Ulta Beauty

$425.30 /

+47.685 (+12.63%)

, DELL

Dell Technologies

$49.57 /

+5.715 (+13.03%)

, COST

Costco

$470.69 /

+5.37 (+1.15%)

, BOOT

Boot Barn

$81.74 /

+3.525 (+4.51%)

, ZS

Zscaler

$159.88 /

+17.55 (+12.33%)

, MRVL

Marvell

$60.83 /

+3.93 (+6.91%)

, BIG

Big Lots

$26.94 /

-3.71 (-12.11%)

, SIGA

Siga Technologies

$13.68 /

+4.04 (+41.91%)

, M

Macy's

$23.45 /

+0.525 (+2.29%)

, IQ

iQIYI

$3.98 /

+0.065 (+1.66%)

, UNH

UnitedHealth

$506.83 /

+4.43 (+0.88%)

, CGC

Canopy Growth

$4.87 /

-0.67 (-12.09%)

, RBGLY

Reckitt Benckiser

$15.65 /

-0.1601 (-1.01%)

, NAVI

Navient

$16.15 /

+0.435 (+2.77%)

, SOFI

SoFi Technologies

$7.56 /

+0.425 (+5.96%)

, NNI

Nelnet

$84.71 /

+0.41 (+0.49%)

, SLM

Sallie Mae

$19.49 /

+0.44 (+2.31%)

, DIDI

Didi

$2.02 /

+0.175 (+9.51%)

, TWTR

Twitter

$40.19 /

+0.66 (+1.67%)

, TSLA

Tesla

$759.79 /

+52.67 (+7.45%)

, FTCH

Farfetch

$9.73 /

+2.05 (+26.69%)

, PMVP

PMV Pharmaceuticals

$15.33 /

+2.11 (+15.96%)

, IOVA

Iovance Biotherapeutics

$7.01 /

-8.105 (-53.64%)

, MRTX

Mirati Therapeutics

$39.80 /

-18.63 (-31.88%)

, WEN

Wendy's

$18.84 /

+0.235 (+1.26%)

, HIBB

Hibbett

$52.49 /

+1.45 (+2.84%)

Get caught up quickly on…

ShowHide Related Items >><<
ZS Zscaler
$159.88 /

+17.55 (+12.33%)

WEN Wendy's
$18.84 /

+0.235 (+1.26%)

WDAY Workday
$158.56 /

-9.5 (-5.65%)

UNH UnitedHealth
$506.83 /

+4.43 (+0.88%)

ULTA Ulta Beauty
$425.30 /

+47.685 (+12.63%)

TWTR Twitter
$40.19 /

+0.66 (+1.67%)

TSLA Tesla
$759.79 /

+52.67 (+7.45%)

SOFI SoFi Technologies
$7.56 /

+0.425 (+5.96%)

SLM Sallie Mae
$19.49 /

+0.44 (+2.31%)

SIGA Siga Technologies
$13.68 /

+4.04 (+41.91%)

PMVP PMV Pharmaceuticals
$15.33 /

+2.11 (+15.96%)

NAVI Navient
$16.15 /

+0.435 (+2.77%)

MRVL Marvell
$60.83 /

+3.93 (+6.91%)

MRTX Mirati Therapeutics
$39.80 /

-18.63 (-31.88%)

M Macy's
$23.45 /

+0.525 (+2.29%)

IQ iQIYI
$3.98 /

+0.065 (+1.66%)

IOVA Iovance Biotherapeutics
$7.01 /

-8.105 (-53.64%)

HIBB Hibbett
$52.49 /

+1.45 (+2.84%)

GPS Gap
$11.60 /

+0.45 (+4.04%)

FTCH Farfetch
$9.73 /

+2.05 (+26.69%)

DIDI Didi
$2.02 /

+0.175 (+9.51%)

DELL Dell Technologies
$49.57 /

+5.715 (+13.03%)

COST Costco
$470.69 /

+5.37 (+1.15%)

CGC Canopy Growth
$4.87 /

-0.67 (-12.09%)

BOOT Boot Barn
$81.74 /

+3.525 (+4.51%)

BIG Big Lots
$26.94 /

-3.71 (-12.11%)

GPS Gap
$11.60 /

+0.45 (+4.04%)

07:01 Today UBS
Gap price target lowered to $11 from $14 at UBS
06:53 Today Deutsche Bank
Gap price target lowered to $12 from $17 at Deutsche Bank
06:51 Today Wells Fargo
Gap price target lowered to $16 from $20 at Wells Fargo
06:51 Today Baird
Gap price target lowered to $11 from $14 at Baird
WDAY Workday
$158.56 /

-9.5 (-5.65%)

09:13 Today DA Davidson
Workday price target lowered to $220 from $250 at DA Davidson
08:46 Today Stifel
Workday price target lowered to $220 from $275 at Stifel
08:37 Today BMO Capital
Workday price target lowered to $239 from $249 at BMO Capital
08:30 Today Needham
Workday price target lowered to $200 from $300 at Needham
ULTA Ulta Beauty
$425.30 /

+47.685 (+12.63%)

09:06 Today DA Davidson
Ulta Beauty price target raised to $465 from $450 at DA Davidson
07:56 Today Oppenheimer
Ulta Beauty price target raised to $485 from $470 at Oppenheimer
07:45 Today Jefferies
Jefferies upgrades Ulta Beauty to Buy after 'signal we'd been waiting for'
06:55 Today Baird
Ulta Beauty price target raised to $490 from $450 at Baird
DELL Dell Technologies
$49.57 /

+5.715 (+13.03%)

08:26 Today BofA
Dell Technologies price target raised to $67 from $65 at BofA
06:54 Today Morgan Stanley
Dell Technologies price target lowered to $56 from $60 at Morgan Stanley
06:51 Today Deutsche Bank
Dell Technologies price target lowered to $60 from $65 at Deutsche Bank
05/25/22 Evercore ISI
Dell Technologies added to 'Tactical Outperform' list at Evercore ISI
COST Costco
$470.69 /

+5.37 (+1.15%)

09:29 Today Truist
Costco price target raised to $543 from $503 at Truist
06:49 Today Baird
Costco price target lowered to $560 from $600 at Baird
06:38 Today Credit Suisse
Costco price target lowered to $550 from $570 at Credit Suisse
06:20 Today Loop Capital
Costco price target lowered to $610 from $650 at Loop Capital
BOOT Boot Barn
$81.74 /

+3.525 (+4.51%)

06:45 Today Baird
Boot Barn upgraded to Outperform from Neutral at Baird
05/11/22 Craig-Hallum
Boot Barn price target lowered to $145 from $162 at Craig-Hallum
05/11/22 JPMorgan
Boot Barn added to Analyst Focus List at JPMorgan
05/06/22 Piper Sandler
Boot Barn upgraded to Overweight from Neutral at Piper Sandler
ZS Zscaler
$159.88 /

+17.55 (+12.33%)

08:00 Today Cowen
Zscaler price target lowered to $194 from $405 at Cowen
07:46 Today Canaccord
Zscaler price target lowered to $210 from $320 at Canaccord
07:21 Today BMO Capital
Zscaler price target lowered to $172 from $270 at BMO Capital
07:06 Today Baird
Zscaler price target lowered to $200 from $300 at Baird
MRVL Marvell
$60.83 /

+3.93 (+6.91%)

09:19 Today BMO Capital
Marvell price target lowered to $82 from $98 at BMO Capital
08:33 Today Needham
Marvell price target lowered to $75 from $105 at Needham
08:11 Today BofA
Marvell price target lowered to $90 from $100 at BofA
07:55 Today Cowen
Marvell price target lowered to $85 from $100 at Cowen
BIG Big Lots
$26.94 /

-3.71 (-12.11%)

05/25/22 Deutsche Bank
Big Lots price target lowered to $31 from $44 at Deutsche Bank
05/24/22 BofA
Big Lots price target lowered to $25 from $31 at BofA
05/20/22 Piper Sandler
Big Lots price target lowered to $29 from $34 at Piper Sandler
05/10/22 JPMorgan
Big Lots price target lowered to $25 from $31 at JPMorgan
SIGA Siga Technologies
$13.68 /

+4.04 (+41.91%)

05/20/22 Benchmark
Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
M Macy's
$23.45 /

+0.525 (+2.29%)

06:53 Today Deutsche Bank
Macy's price target lowered to $29 from $34 at Deutsche Bank
06:47 Today Citi
Macy's price target lowered to $23 from $25 at Citi
05:07 Today Morgan Stanley
Macy's upgraded to Equal Weight from Underweight at Morgan Stanley
05/16/22 JPMorgan
Macy's price target lowered to $30 from $33 at JPMorgan
IQ iQIYI
$3.98 /

+0.065 (+1.66%)

06:21 Today Benchmark
iQIYI upgraded to Buy from Hold at Benchmark
05/26/22 Citi
Citi upgrades iQIYI on earlier than expected profitability
05/26/22 Citi
iQIYI upgraded to Buy from Neutral at Citi
05/16/22 JPMorgan
iQIYI upgraded to Overweight from Underweight at JPMorgan
UNH UnitedHealth
$506.83 /

+4.43 (+0.88%)

05/26/22 Bernstein
UnitedHealth downgraded to Market Perform at Bernstein on valuation
05/26/22 Bernstein
UnitedHealth downgraded to Market Perform from Outperform at Bernstein
05/11/22 Citi
MultiPlan price target raised to $6.50 from $6 at Citi
04/26/22 Piper Sandler
Piper 'incrementally confident' Change, UNH will prevail in August
CGC Canopy Growth
$4.87 /

-0.67 (-12.09%)

14:10 Today Alliance Global Partners
Canopy Growth price target lowered to C$7 from C$8 at Alliance Global Partners
12:51 Today Benchmark
Canopy Growth cut to Sell at Benchmark after 'disappointing' quarter
12:47 Today Benchmark
Canopy Growth downgraded to Sell from Hold at Benchmark
05/20/22 Alliance Global Partners
Canopy Growth price target lowered to C$8 from C$11 at Alliance Global Partners
RBGLY Reckitt Benckiser
$15.65 /

-0.1601 (-1.01%)

05/18/22 RBC Capital
Reckitt Benckiser upgraded to Outperform from Sector Perform at RBC Capital
05/09/22 Morgan Stanley
Reckitt Benckiser price target raised to 7,100 GBp at Morgan Stanley
05/03/22 RBC Capital
Reckitt Benckiser price target raised to 5,900 GBp at RBC Capital
05/03/22 Barclays
Reckitt Benckiser price target raised to 9,300 GBp from 9,100 GBp at Barclays
NAVI Navient
$16.15 /

+0.435 (+2.77%)

04/11/22 JPMorgan
Navient cut to Underweight at JPMorgan on student lending normalization delay
04/11/22 JPMorgan
Navient downgraded to Underweight from Neutral at JPMorgan
03/31/22 Compass Point
Navient downgraded to Neutral from Buy at Compass Point
01/27/22 JPMorgan
Navient price target lowered to $21 from $23 at JPMorgan
SOFI SoFi Technologies
$7.56 /

+0.425 (+5.96%)

05/17/22 Mizuho
SoFi Technologies price target lowered to $9 from $14 at Mizuho
05/16/22 Piper Sandler
Piper upgrades SoFi to buy ahead of 'significant' earnings ramp
05/16/22 Piper Sandler
SoFi Technologies upgraded to Overweight from Neutral at Piper Sandler
05/12/22 Citi
SoFi Technologies price target lowered to $11 from $17 at Citi
NNI Nelnet
$84.71 /

+0.41 (+0.49%)

01/13/22 Credit Suisse
Nelnet downgraded to Neutral from Outperform at Credit Suisse
SLM Sallie Mae
$19.49 /

+0.44 (+2.31%)

05/02/22 Citi
Sallie Mae price target lowered to $21 from $26 at Citi
04/18/22 Stephens
Sallie Mae downgraded to Equal Weight from Overweight at Stephens
01/10/22 Barclays
Sallie Mae price target raised to $27 from $25 at Barclays
07/22/21 Stephens
Stephens 'surprised' by Sallie Mae stock underperformance, ups target to $23
DIDI Didi
$2.02 /

+0.175 (+9.51%)

03/16/22 US Tiger
China Internet sector upgraded to Outperform from Neutral at US Tiger
02/14/22 Bernstein
Didi initiated with an Outperform at Bernstein
07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
TWTR Twitter
$40.19 /

+0.66 (+1.67%)

05/24/22 Jefferies
Twitter price target lowered to $40 from $48 at Jefferies
05/24/22 Wedbush
More fireworks expected heading into Twitter shareholder meeting, says Wedbush
05/24/22 KeyBanc
Snap price target lowered to $27 from $45 at KeyBanc
05/24/22 Bernstein
Bernstein says Tesla-Twitter saga far from over, discusses funding requirements
TSLA Tesla
$759.79 /

+52.67 (+7.45%)

05:44 Today Credit Suisse
Tesla pullback brings attractive entry point, says Credit Suisse
05/26/22 Jefferies
Jefferies cuts Tesla price target on governance risk, challenging market
FTCH Farfetch
$9.73 /

+2.05 (+26.69%)

07:48 Today Wedbush
Farfetch price target lowered to $8 from $16 at Wedbush
07:23 Today Morgan Stanley
Farfetch price target lowered to $30 from $56 at Morgan Stanley
06:53 Today Wells Fargo
Farfetch price target lowered to $25 from $35 at Wells Fargo
06:30 Today BTIG
Farfetch price target lowered to $16 from $26 at BTIG
PMVP PMV Pharmaceuticals
$15.33 /

+2.11 (+15.96%)

03/02/22 Oppenheimer
Oppenheimer upgrades PMV Pharmaceuticals to Outperform with $30 price target
03/02/22 Oppenheimer
PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
09/22/21 Goldman Sachs
PMV Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
08/19/21 Oppenheimer
PMV Pharmaceuticals initiated with a Perform at Oppenheimer
IOVA Iovance Biotherapeutics
$7.01 /

-8.105 (-53.64%)

08:19 Today H.C. Wainwright
Iovance Biotherapeutics 'close to the finish line,' says H.C. Wainwright
07:55 Today Oppenheimer
Iovance Biotherapeutics price target lowered to $27 from $31 at Oppenheimer
07:41 Today Stifel
Iovance Biotherapeutics after-hours stock reaction seems 'overdone,' says Stifel
07:36 Today Chardan
Iovance Biotherapeutics price target lowered to $31 from $44 at Chardan
MRTX Mirati Therapeutics
$39.80 /

-18.63 (-31.88%)

10:03 Today Stifel
Mirati Therapeutics after-hours move lower 'overdone,' says Stifel
05/20/22 Guggenheim
Guggenheim upgrades Mirati to Buy on adagrasib's 'highly competitive profile'
05/20/22 Guggenheim
Mirati Therapeutics upgraded to Buy from Neutral at Guggenheim
05/05/22 Stifel
ASCO sets up as 'downside-biased' for Mirati investors, says Stifel
WEN Wendy's
$18.84 /

+0.235 (+1.26%)

05/25/22 MKM Partners
Wendy's may see more 'value unlocks' from strategic options, says MKM Partners
05/25/22 Wedbush
Wedbush remains bullish on Wendy's, not surprised by Trian news
05/25/22 Stifel
Wendy's deal in 'low-$20 range' would be 'feasible,' says Stifel
05/12/22 Truist
Wendy's price target lowered to $27 from $29 at Truist
HIBB Hibbett
$52.49 /

+1.45 (+2.84%)

14:27 Today Baird
Hibbett price target lowered to $70 from $75 at Baird
03/07/22 Benchmark
Hibbett price target lowered to $80 from $125 at Benchmark
02/22/22 Monness Crespi
Hibbett price target lowered to $80 from $120 at Monness Crespi
02/21/22 Baird
Hibbett price target lowered to $75 from $100 at Baird
ZS Zscaler
$159.88 /

+17.55 (+12.33%)

WEN Wendy's
$18.84 /

+0.235 (+1.26%)

WDAY Workday
$158.56 /

-9.5 (-5.65%)

UNH UnitedHealth
$506.83 /

+4.43 (+0.88%)

ULTA Ulta Beauty
$425.30 /

+47.685 (+12.63%)

TWTR Twitter
$40.19 /

+0.66 (+1.67%)

TSLA Tesla
$759.79 /

+52.67 (+7.45%)

SOFI SoFi Technologies
$7.56 /

+0.425 (+5.96%)

SLM Sallie Mae
$19.49 /

+0.44 (+2.31%)

SIGA Siga Technologies
$13.68 /

+4.04 (+41.91%)

PMVP PMV Pharmaceuticals
$15.33 /

+2.11 (+15.96%)

NAVI Navient
$16.15 /

+0.435 (+2.77%)

MRVL Marvell
$60.83 /

+3.93 (+6.91%)

MRTX Mirati Therapeutics
$39.80 /

-18.63 (-31.88%)

M Macy's
$23.45 /

+0.525 (+2.29%)

IQ iQIYI
$3.98 /

+0.065 (+1.66%)

IOVA Iovance Biotherapeutics
$7.01 /

-8.105 (-53.64%)

HIBB Hibbett
$52.49 /

+1.45 (+2.84%)

GPS Gap
$11.60 /

+0.45 (+4.04%)

FTCH Farfetch
$9.73 /

+2.05 (+26.69%)

DIDI Didi
$2.02 /

+0.175 (+9.51%)

DELL Dell Technologies
$49.57 /

+5.715 (+13.03%)

COST Costco
$470.69 /

+5.37 (+1.15%)

CGC Canopy Growth
$4.87 /

-0.67 (-12.09%)

BOOT Boot Barn
$81.74 /

+3.525 (+4.51%)

BIG Big Lots
$26.94 /

-3.71 (-12.11%)

  • 16
    Nov
  • 11
    Nov
  • 30
    Jun
ZS Zscaler
$159.88 /

+17.55 (+12.33%)

WEN Wendy's
$18.84 /

+0.235 (+1.26%)

WDAY Workday
$158.56 /

-9.5 (-5.65%)

UNH UnitedHealth
$506.83 /

+4.43 (+0.88%)

TWTR Twitter
$40.19 /

+0.66 (+1.67%)

TSLA Tesla
$759.79 /

+52.67 (+7.45%)

RBGLY Reckitt Benckiser
$15.65 /

-0.1601 (-1.01%)

PMVP PMV Pharmaceuticals
$15.33 /

+2.11 (+15.96%)

NNI Nelnet
$84.71 /

+0.41 (+0.49%)

NAVI Navient
$16.15 /

+0.435 (+2.77%)

M Macy's
$23.45 /

+0.525 (+2.29%)

IQ iQIYI
$3.98 /

+0.065 (+1.66%)

HIBB Hibbett
$52.49 /

+1.45 (+2.84%)

GPS Gap
$11.60 /

+0.45 (+4.04%)

DIDI Didi
$2.02 /

+0.175 (+9.51%)

DELL Dell Technologies
$49.57 /

+5.715 (+13.03%)

CGC Canopy Growth
$4.87 /

-0.67 (-12.09%)

ZS Zscaler
$159.88 /

+17.55 (+12.33%)

WEN Wendy's
$18.84 /

+0.235 (+1.26%)

WDAY Workday
$158.56 /

-9.5 (-5.65%)

ULTA Ulta Beauty
$425.30 /

+47.685 (+12.63%)

TWTR Twitter
$40.19 /

+0.66 (+1.67%)

TSLA Tesla
$759.79 /

+52.67 (+7.45%)

SOFI SoFi Technologies
$7.56 /

+0.425 (+5.96%)

SIGA Siga Technologies
$13.68 /

+4.04 (+41.91%)

NAVI Navient
$16.15 /

+0.435 (+2.77%)

MRVL Marvell
$60.83 /

+3.93 (+6.91%)

MRTX Mirati Therapeutics
$39.80 /

-18.63 (-31.88%)

M Macy's
$23.45 /

+0.525 (+2.29%)

IQ iQIYI
$3.98 /

+0.065 (+1.66%)

IOVA Iovance Biotherapeutics
$7.01 /

-8.105 (-53.64%)

HIBB Hibbett
$52.49 /

+1.45 (+2.84%)

GPS Gap
$11.60 /

+0.45 (+4.04%)

FTCH Farfetch
$9.73 /

+2.05 (+26.69%)

DIDI Didi
$2.02 /

+0.175 (+9.51%)

DELL Dell Technologies
$49.57 /

+5.715 (+13.03%)

COST Costco
$470.69 /

+5.37 (+1.15%)

CGC Canopy Growth
$4.87 /

-0.67 (-12.09%)

BOOT Boot Barn
$81.74 /

+3.525 (+4.51%)

BIG Big Lots
$26.94 /

-3.71 (-12.11%)

ZS Zscaler
$159.88 /

+17.55 (+12.33%)

WEN Wendy's
$18.84 /

+0.235 (+1.26%)

WDAY Workday
$158.56 /

-9.5 (-5.65%)

UNH UnitedHealth
$506.83 /

+4.43 (+0.88%)

ULTA Ulta Beauty
$425.30 /

+47.685 (+12.63%)

TWTR Twitter
$40.19 /

+0.66 (+1.67%)

TSLA Tesla
$759.79 /

+52.67 (+7.45%)

SOFI SoFi Technologies
$7.56 /

+0.425 (+5.96%)

SIGA Siga Technologies
$13.68 /

+4.04 (+41.91%)

NAVI Navient
$16.15 /

+0.435 (+2.77%)

MRVL Marvell
$60.83 /

+3.93 (+6.91%)

M Macy's
$23.45 /

+0.525 (+2.29%)

IQ iQIYI
$3.98 /

+0.065 (+1.66%)

IOVA Iovance Biotherapeutics
$7.01 /

-8.105 (-53.64%)

GPS Gap
$11.60 /

+0.45 (+4.04%)

FTCH Farfetch
$9.73 /

+2.05 (+26.69%)

DIDI Didi
$2.02 /

+0.175 (+9.51%)

DELL Dell Technologies
$49.57 /

+5.715 (+13.03%)

COST Costco
$470.69 /

+5.37 (+1.15%)

CGC Canopy Growth
$4.87 /

-0.67 (-12.09%)

BOOT Boot Barn
$81.74 /

+3.525 (+4.51%)

BIG Big Lots
$26.94 /

-3.71 (-12.11%)

Syndicate
Metalla Royalty & Streaming announces updated at-the-market program for $50M » 16:37
05/27/22
05/27
16:37
05/27/22
16:37
MTA

Metalla Royalty & Streaming

$5.62 /

+0.175 (+3.21%)

Metalla Royalty &…

Metalla Royalty & Streaming is pleased to announce that it has entered into a new equity distribution agreement with a syndicate of agents including BMO Nesbitt Burns Inc., PI Financial Corp., and Scotia Capital Inc., as the Canadian agents, and BMO Capital Markets Corp. and Scotia Capital Inc., as the United States agents, for a new at-the-market equity program. The Distribution Agreement will allow the Company to distribute up to $50 million of common shares of the Company under the 2022 ATM Program. The Offered Shares will be issued by the Company to the public from time to time, through the Agents, at the Company's discretion. The Offered Shares sold under the 2022 ATM Program, if any, will be sold at the prevailing market price at the time of sale.

ShowHide Related Items >><<
MTA Metalla Royalty & Streaming
$5.62 /

+0.175 (+3.21%)

MTA Metalla Royalty & Streaming
$5.62 /

+0.175 (+3.21%)

09/16/21 Scotiabank
Metalla Royalty & Streaming initiated with a Sector Perform at Scotiabank
Initiation
BNP Paribas initiated with Not Rated at Goldman Sachs » 16:37
05/27/22
05/27
16:37
05/27/22
16:37
BNPQY

BNP Paribas

$28.95 /

+0.585 (+2.06%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BNPQY BNP Paribas
$28.95 /

+0.585 (+2.06%)

BNPQY BNP Paribas
$28.95 /

+0.585 (+2.06%)

05/25/22 Deutsche Bank
BNP Paribas price target raised to EUR 66 from EUR 64 at Deutsche Bank
05/05/22 UBS
BNP Paribas price target raised to EUR 63 from EUR 60 at UBS
05/05/22 JPMorgan
BNP Paribas price target raised to EUR 62 from EUR 61 at JPMorgan
05/04/22 Barclays
BNP Paribas price target raised to EUR 64.30 from EUR 62.30 at Barclays
BNPQY BNP Paribas
$28.95 /

+0.585 (+2.06%)

BNPQY BNP Paribas
$28.95 /

+0.585 (+2.06%)

Initiation
Societe Generale initiated with a Neutral at Goldman Sachs » 16:36
05/27/22
05/27
16:36
05/27/22
16:36
SCGLY

Societe Generale

$5.40 /

+0.02 (+0.37%)

Goldman Sachs analyst…

Goldman Sachs analyst Chris Hallam initiated coverage of Societe Generale with a Neutral rating and EUR 35 price target. The analyst believes the company "should see growth supported in the coming years by higher interest rates in the traditional banking business and elevated activity levels in Global Markets," however he adds that the company is "not as geared to rates as peers, consensus estimates already imply Global Markets revenue targets will be exceeded and Boursorama's success will make a relatively small impact at a group level over 2023/24."

ShowHide Related Items >><<
SCGLY Societe Generale
$5.40 /

+0.02 (+0.37%)

SCGLY Societe Generale
$5.40 /

+0.02 (+0.37%)

05/25/22 RBC Capital
Societe Generale price target raised to EUR 32 from EUR 29 at RBC Capital
05/19/22 JPMorgan
Societe Generale price target raised to EUR 33 from EUR 29 at JPMorgan
05/19/22 Keefe Bruyette
Societe Generale upgraded on Russia assets sale at Keefe Bruyette
05/18/22 Keefe Bruyette
Societe Generale upgraded to Outperform from Market Perform at Keefe Bruyette
Hot Stocks
JinkoSolar subsidiary signs new distribution agreement in Latin America » 16:35
05/27/22
05/27
16:35
05/27/22
16:35
JKS

JinkoSolar

$59.01 /

-1.195 (-1.98%)

JinkoSolar announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JKS JinkoSolar
$59.01 /

-1.195 (-1.98%)

JKS JinkoSolar
$59.01 /

-1.195 (-1.98%)

03/24/22 UBS
JinkoSolar price target raised to $52 from $44 at UBS
01/31/22 Goldman Sachs
JinkoSolar price target lowered to $26 from $29 at Goldman Sachs
01/14/22 GLJ Research
GLJ Research says 'likely a great time to aggressively short' JinkoSolar
01/11/22 GLJ Research
Solar bulls 'could be disappointed' about CPUC this week, says GLJ Research
JKS JinkoSolar
$59.01 /

-1.195 (-1.98%)

JKS JinkoSolar
$59.01 /

-1.195 (-1.98%)

JKS JinkoSolar
$59.01 /

-1.195 (-1.98%)

JKS JinkoSolar
$59.01 /

-1.195 (-1.98%)

Hot Stocks
China Green discloses NYSE notice regarding late 10-Q filing » 16:35
05/27/22
05/27
16:35
05/27/22
16:35
CGA

China Green

$7.45 /

-0.05 (-0.67%)

China Green…

China Green "announced that, as a result of its failure to file its Quarterly Report on Form 10-Q for the period ended March 31, 2022 in a timely fashion, it has received a notice from the New York Stock Exchange that the Company was not in compliance with the NYSE's continued listing requirements under the timely filing criteria established in Section 802.01E of the NYSE Listed Company Manual. As reported by the Company in its Form 12b-25 filed with the Securities and Exchange Commission on May 17, 2022, the Company was unable to file the Form 10-Q within the prescribed time period without unreasonable effort or expense. The extension period provided under Rule 12b-25 expired on May 23, 2022. The Company is unable to meet the filing deadline for the filing of its Form 10-Q due to circumstances related to COVID-19. In the year of 2022, more pandemic restrictions had been tightened throughout China to control the spread of COVID-19 in the community. As the Company's primary business is in China, its operations had been impacted due to the pandemic restrictions. The Company is currently working closely with its principal accounting firm to complete the filing of its Form 10-Q as soon as reasonably practicable."

ShowHide Related Items >><<
CGA China Green
$7.45 /

-0.05 (-0.67%)

Initiation
Credit Agricole initiated with a Neutral at Goldman Sachs » 16:34
05/27/22
05/27
16:34
05/27/22
16:34
CRARY

Credit Agricole

$5.60 /

-0.069 (-1.22%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRARY Credit Agricole
$5.60 /

-0.069 (-1.22%)

CRARY Credit Agricole
$5.60 /

-0.069 (-1.22%)

05/19/22 Berenberg
Credit Agricole price target lowered to EUR 11.50 from EUR 12.30 at Berenberg
05/19/22 JPMorgan
Credit Agricole downgraded to Underweight from Neutral at JPMorgan
05/17/22 UBS
Credit Agricole price target lowered to EUR 12.40 from EUR 13.40 at UBS
05/06/22 Credit Suisse
Credit Agricole price target lowered to EUR 12 from EUR 12.50 at Credit Suisse
Syndicate
Bio-Path files $110M mixed securities shelf  16:32
05/27/22
05/27
16:32
05/27/22
16:32
BPTH

Bio-Path

$3.54 /

+0.28 (+8.59%)

 
ShowHide Related Items >><<
BPTH Bio-Path
$3.54 /

+0.28 (+8.59%)

BPTH Bio-Path
$3.54 /

+0.28 (+8.59%)

05/18/22 H.C. Wainwright
Bio-Path price target lowered to $9 from $12 at H.C. Wainwright
BPTH Bio-Path
$3.54 /

+0.28 (+8.59%)

Initiation
UniCredit initiated with a Buy at Goldman Sachs » 16:32
05/27/22
05/27
16:32
05/27/22
16:32
UNCRY

UniCredit

$5.79 /

+0.03 (+0.52%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UNCRY UniCredit
$5.79 /

+0.03 (+0.52%)

UNCRY UniCredit
$5.79 /

+0.03 (+0.52%)

05/19/22 JPMorgan
UniCredit price target lowered to EUR 11.70 from EUR 12 at JPMorgan
05/09/22 Deutsche Bank
UniCredit price target lowered to EUR 14.60 from EUR 15.50 at Deutsche Bank
05/09/22 Credit Suisse
UniCredit price target raised to EUR 14 from EUR 13.80 at Credit Suisse
04/25/22 Morgan Stanley
UniCredit price target lowered to EUR 16.50 from EUR 19.50 at Morgan Stanley
UNCRY UniCredit
$5.79 /

+0.03 (+0.52%)

UNCRY UniCredit
$5.79 /

+0.03 (+0.52%)

Initiation
Intesa Sanpaolo initiated with a Buy at Goldman Sachs » 16:30
05/27/22
05/27
16:30
05/27/22
16:30
ISNPY

Intesa Sanpaolo

$13.24 /

-0.04 (-0.30%)

Goldman Sachs analyst…

Goldman Sachs analyst Chris Hallam initiated coverage of Intesa Sanpaolo with a Buy rating and EUR 3.25 price target. The analyst believes that the recent move in interest rates is "set to drive higher-than-expected NII and group revenues, more than offsetting pressure on fees from lower asset values."

ShowHide Related Items >><<
ISNPY Intesa Sanpaolo
$13.24 /

-0.04 (-0.30%)

05/19/22 JPMorgan
Intesa Sanpaolo price target raised to EUR 2.80 from EUR 2.70 at JPMorgan
05/10/22 Deutsche Bank
Intesa Sanpaolo price target lowered to EUR 2.90 from EUR 3.10 at Deutsche Bank
05/09/22 Credit Suisse
Intesa Sanpaolo price target lowered to EUR 2 from EUR 2.30 at Credit Suisse
04/26/22 DZ Bank
Intesa Sanpaolo downgraded to Hold from Buy at DZ Bank
Options
Preliminary option volume of 44.6M today » 16:30
05/27/22
05/27
16:30
05/27/22
16:30

Preliminary option volume…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Nvidia recommends shareholders reject 'mini-tender' offer from Tutanota » 16:29
05/27/22
05/27
16:29
05/27/22
16:29
NVDA

Nvidia

$188.30 /

+9.82 (+5.50%)

Nvidia announced that it…

Nvidia announced that it recently became aware of an unsolicited "mini-tender" offer by Tutanota to purchase up to 215,000 shares of Nvidia common stock, representing significantly less than 1% of Nvidia's outstanding common stock. The offer price of $210 per share is conditioned on, among other things, the closing price per share of Nvidia's common stock exceeding $210 per share on the last trading day before the offer expires. This means that unless Tutanota waives this condition, Nvidia stockholders who tender their shares in the offer will receive a below-market price. Nvidia cautions stockholders that Tutanota has stated it expects to extend the offer for successive periods of 45 to 180 days, in which case payment would be delayed beyond the scheduled expiration date of Friday, May 27. There is no guarantee that the conditions of the offer will be satisfied. Nvidia recommends that stockholders do not tender their shares in response to Tutanota's offer because the offer requires that the closing price per share of Nvidia's common stock exceed the offer price, and the offer is subject to numerous additional conditions, including Tutanota obtaining financing for the offer. Stockholders who have already tendered their shares may withdraw them at any time by providing notice in accordance with the Tutanota offering documents prior to the expiration of the offer, which is currently scheduled for 5 p.m. Eastern Daylight Time on Friday, May 27.

ShowHide Related Items >><<
NVDA Nvidia
$188.30 /

+9.82 (+5.50%)

NVDA Nvidia
$188.30 /

+9.82 (+5.50%)

07:02 Today Baird
Nvidia price target lowered to $165 from $225 at Baird
05/26/22 Needham
Nvidia price target lowered to $240 from $400 at Needham
05/26/22 Evercore ISI
Nvidia shares 'too cheap to ignore,' says Evercore ISI
05/26/22 Jefferies
Jefferies says 'buy the confession' after Nvidia's April quarter report
NVDA Nvidia
$188.30 /

+9.82 (+5.50%)

NVDA Nvidia
$188.30 /

+9.82 (+5.50%)

NVDA Nvidia
$188.30 /

+9.82 (+5.50%)

NVDA Nvidia
$188.30 /

+9.82 (+5.50%)

Hot Stocks
Renren signs amendment to stipulation of shareholder derivative settlement » 16:23
05/27/22
05/27
16:23
05/27/22
16:23
RENN

Renren

$28.60 /

+0.38 (+1.35%)

Renren announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RENN Renren
$28.60 /

+0.38 (+1.35%)

Syndicate
GCM Grosvenor files $350M mixed securities shelf  16:20
05/27/22
05/27
16:20
05/27/22
16:20
GCMG

GCM Grosvenor

$8.44 /

+0.205 (+2.49%)

 
ShowHide Related Items >><<
GCMG GCM Grosvenor
$8.44 /

+0.205 (+2.49%)

GCMG GCM Grosvenor
$8.44 /

+0.205 (+2.49%)

04/13/22 Oppenheimer
GCM Grosvenor price target lowered to $11 from $12 at Oppenheimer
12/14/21 UBS
GCM Grosvenor initiated with a Neutral at UBS
12/14/21 UBS
GCM Grosvenor initiated with a Neutral at UBS
08/31/21 Oppenheimer
GCM Grosvenor initiated with an Outperform at Oppenheimer
GCMG GCM Grosvenor
$8.44 /

+0.205 (+2.49%)

GCMG GCM Grosvenor
$8.44 /

+0.205 (+2.49%)

Options
Closing CBOE SPX and VIX Index summary for May 27th » 16:20
05/27/22
05/27
16:20
05/27/22
16:20
VIX

Volatility Index S&P 500 Options

/

+

The CBOE Volatility Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIX Volatility Index S&P 500 Options
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.